Correlation Between Design Therapeutics and Ayala Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Design Therapeutics and Ayala Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Design Therapeutics and Ayala Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Design Therapeutics and Ayala Pharmaceuticals, you can compare the effects of market volatilities on Design Therapeutics and Ayala Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Design Therapeutics with a short position of Ayala Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Design Therapeutics and Ayala Pharmaceuticals.
Diversification Opportunities for Design Therapeutics and Ayala Pharmaceuticals
-0.33 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Design and Ayala is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and Ayala Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ayala Pharmaceuticals and Design Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Design Therapeutics are associated (or correlated) with Ayala Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ayala Pharmaceuticals has no effect on the direction of Design Therapeutics i.e., Design Therapeutics and Ayala Pharmaceuticals go up and down completely randomly.
Pair Corralation between Design Therapeutics and Ayala Pharmaceuticals
Given the investment horizon of 90 days Design Therapeutics is expected to generate 19.3 times less return on investment than Ayala Pharmaceuticals. But when comparing it to its historical volatility, Design Therapeutics is 2.49 times less risky than Ayala Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Ayala Pharmaceuticals is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 170.00 in Ayala Pharmaceuticals on August 26, 2024 and sell it today you would lose (32.00) from holding Ayala Pharmaceuticals or give up 18.82% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 31.79% |
| Values | Daily Returns |
Design Therapeutics vs. Ayala Pharmaceuticals
Performance |
| Timeline |
| Design Therapeutics |
| Ayala Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Design Therapeutics and Ayala Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Design Therapeutics and Ayala Pharmaceuticals
The main advantage of trading using opposite Design Therapeutics and Ayala Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Design Therapeutics position performs unexpectedly, Ayala Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ayala Pharmaceuticals will offset losses from the drop in Ayala Pharmaceuticals' long position.| Design Therapeutics vs. Monte Rosa Therapeutics | Design Therapeutics vs. Werewolf Therapeutics | Design Therapeutics vs. Ikena Oncology | Design Therapeutics vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |